Now Available
Expand 
Collapse
Collapse INDICATION AND IMPORTANT
SAFETY INFORMATION
INDICATION
MIEBO™ (perfluorohexyloctane ophthalmic solution) is used to treat the signs and symptoms of dry eye disease.
IMPORTANT SAFETY INFORMATION
- Remove contact lenses before using MIEBO and wait for at least 30 minutes before reinserting
- It is important to use MIEBO exactly as prescribed
- It is not known if MIEBO is safe and effective in children under the age of 18
- The most common eye side effect seen in studies was blurred vision (1% to 3% of patients reported blurred vision and eye redness)
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
Click here for full Prescribing Information for MIEBO.
FAQs
MIEBO is the first & only Rx eye drop that directly targets the leading cause of dry eye: tear evaporation, which causes symptoms such as dryness and that scratchy, gritty feeling. MIEBO is made from only one ingredient—it’s both preservative and steroid-free.
MIEBO is a small, comfortable drop that spreads quickly across your eye, coating it in a protective layer. In clinical studies, 8 out of 10 people found MIEBO comfortable or very comfortable when applied.*
*In the studies, 81% of people treated with MIEBO rated it as a 7 or higher on a 0–10 comfort scale.
MIEBO is an FDA-approved Rx drop that has been tested in 2 clinical studies and can only be prescribed by a doctor. In those studies, few people reported burning or stinging, and 1% to 3% of people using MIEBO reported eye redness or blurred vision as a side effect (which usually resolved within minutes).
INDICATION
MIEBO™ (perfluorohexyloctane ophthalmic solution) is used to treat the signs and symptoms of dry eye disease.
IMPORTANT SAFETY INFORMATION
- Remove contact lenses before using MIEBO and wait for at least 30 minutes before reinserting
- It is important to use MIEBO exactly as prescribed
- It is not known if MIEBO is safe and effective in children under the age of 18
- The most common eye side effect seen in studies was blurred vision (1% to 3% of patients reported blurred vision and eye redness)
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
Click here for full Prescribing Information for MIEBO.